Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT01560949
First received: March 20, 2012
Last updated: December 5, 2016
Last verified: December 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: June 2018 (Final data collection date for primary outcome measure)